Company profile
MiNA Therapeutics | RNA Activation MiNA Therapeutics | RNA Activation
Mina Therapeutics Limited is a UK company with status active founded in 2008.
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
CS01 | Transaction MzUxNjY4MzUzNGFkaXF6a2N4
Published 16 Apr 2026 14:39
RP01AP01 | Transaction MzUxMzIyMjAyNWFkaXF6a2N4
Published 16 Apr 2026 13:54
Last confirmation statement made up date
AP01 | Transaction MzQ1NjczNDUzNmFkaXF6a2N4 | Paper/PDF filed
Published 17 Apr 2026 01:36
Last accounts made up date
AP01 | Transaction MzQzMjQ3OTgzMmFkaXF6a2N4
Published 16 Aug 2024 10:19
TM01 | Transaction MzQzMjQ3OTgzOGFkaXF6a2N4
Published 16 Aug 2024 10:14
Company registered at Companies House
1 Jul 2022 to 31 Oct 2023
Aniridia is a rare disease where patients' eyes develop improperly due to a genetic mutation in a gene called PAX6\. Although rare, the disease has a dramatic detrimental impact of patients' quality of life. Importantly, although the patients are born with eye problems, the worst aspects of disease occur later in life. The biggest problem occurs in the te...
